Spyre Therapeutics SYRE
NASDAQ SYRE
$105.71 +1.23 (+1.18%)
As of: Nov 11, 2026 · 12:56 PM EST

Spyre Therapeutics (SYRE) Liabilities and Shareholders Equity (2015 - 2026)

Updated

Analysis

Spyre Therapeutics (SYRE) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Spyre Therapeutics 9.40 Bn 5.68 Bn - 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.10 Bn
Jun 30, 2026 1.17 Bn
Mar 31, 2026 763.95 Mn
Dec 31, 2025 777.78 Mn
Sep 30, 2025 504.60 Mn
Jun 30, 2025 538.83 Mn
Mar 31, 2025 569.78 Mn
Dec 31, 2024 608.48 Mn
Sep 30, 2024 421.09 Mn
Jun 30, 2024 436.07 Mn
Mar 31, 2024 487.60 Mn
Dec 31, 2023 341.86 Mn
Sep 30, 2023 207.27 Mn
Jun 30, 2023 243.53 Mn
Mar 31, 2023 52.45 Mn
Dec 31, 2022 71.14 Mn
Sep 30, 2022 91.57 Mn
Jun 30, 2022 106.71 Mn
Mar 31, 2022 83.17 Mn
Dec 31, 2021 109.93 Mn
API Access

Spyre Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SYRE&period=max&api_key=YOUR_API_KEY